Point-of-Care or Rapid Testing Market
Point-of-Care or Rapid Testing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Point-of-Care or Rapid Testing Market Size and Growth
The Point-of-Care or Rapid Testing market is experiencing substantial growth, driven by increased demand for quick diagnostics, especially in infectious diseases. As of 2023, the market size is estimated to exceed $24 billion, with projections suggesting a compound annual growth rate (CAGR) of around 10% over the next five years. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ Abbott
◍ Johnson & Johnson
◍ Siemens Healthcare
◍ Danaher
◍ Ascensia
◍ Bio-Rad Laboratories
◍ BioMerieux
◍ ARKRAY
◍ Nova Biomedical
◍ Trividia Health
◍ Quidel
◍ Accriva
◍ OraSure Technologies
◍ Helena Laboratories
◍ A. Menarini Diagnostics
◍ Abaxis (Zoetis)
◍ Ortho Clinical Diagnostics
The Point-of-Care testing market features major players like Roche, Abbott, and Johnson & Johnson, leveraging innovations in diagnostics to enhance healthcare access. These companies provide rapid tests for various conditions, driving market growth through strategic partnerships and product development. Revenue estimates include:
- Roche: ~$14 billion (2021)
- Abbott: ~$43 billion (2022)
- Siemens Healthcare: ~$20 billion (2022)
- Danaher: ~$31 billion (2022)
Request Sample Report
